Drug intelligence / Profile preview

cocaethylene

Development stage
Phase 1
Modality
Small Molecules
Administration
Not Applicable (formed Endogenously After Oral/intranasal/intravenous Use Of Both Alcohol And Cocaine)
01

Overview

Cocaethylene is a psychoactive and toxic compound formed in the liver when cocaine and alcohol are consumed together. Chemically, it is the ethyl ester of benzoylecgonine, structurally similar to cocaine (which is the methyl ester). Cocaethylene acts as a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI), increasing levels of these neurotransmitters in the brain. It has a higher affinity for the dopamine transporter than cocaine but lower affinity for serotonin and norepinephrine transporters. The substance produces stimulant, euphoriant, anorectic, sympathomimetic, and local anesthetic effects with a longer duration of action than cocaine. Cocaethylene is significantly more toxic than either cocaine or alcohol alone; it increases risks of heart damage, liver failure, seizures, overdose, and sudden death—carrying an 18- to 25-fold increased risk of immediate death compared to cocaine alone[2][3][5][7]. It also impairs judgment and can lead to more intense highs that last longer due to its slower elimination from the body[3][6].

Other names
ethylbenzoylecgonine
02

Targets

NET (Norepinephrine Transporter)DAT (Dopamine plasma membrane transport protein)SERT (Sodium-dependent serotonin transporter)

Beyond the preview

Go deeper on cocaethylene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cocaethylene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call